IL144559A0 - Antibodies for cancer therapy and diagnosis - Google Patents
Antibodies for cancer therapy and diagnosisInfo
- Publication number
- IL144559A0 IL144559A0 IL14455900A IL14455900A IL144559A0 IL 144559 A0 IL144559 A0 IL 144559A0 IL 14455900 A IL14455900 A IL 14455900A IL 14455900 A IL14455900 A IL 14455900A IL 144559 A0 IL144559 A0 IL 144559A0
- Authority
- IL
- Israel
- Prior art keywords
- antibodies
- application
- diagnosis
- daf
- directed against
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12226299P | 1999-03-01 | 1999-03-01 | |
PCT/US2000/005352 WO2000052054A2 (fr) | 1999-03-01 | 2000-02-29 | Anticorps destines au traitement et au diagnostic du cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
IL144559A0 true IL144559A0 (en) | 2002-05-23 |
Family
ID=22401661
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14455900A IL144559A0 (en) | 1999-03-01 | 2000-02-29 | Antibodies for cancer therapy and diagnosis |
IL144559A IL144559A (en) | 1999-03-01 | 2001-07-25 | Antibodies for cancer therapy and diagnosis |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL144559A IL144559A (en) | 1999-03-01 | 2001-07-25 | Antibodies for cancer therapy and diagnosis |
Country Status (11)
Country | Link |
---|---|
US (2) | US7288249B2 (fr) |
EP (1) | EP1157041B1 (fr) |
JP (1) | JP2002543044A (fr) |
AT (1) | ATE296839T1 (fr) |
AU (1) | AU770952B2 (fr) |
CA (1) | CA2361877A1 (fr) |
DE (1) | DE60020529T2 (fr) |
ES (1) | ES2243240T3 (fr) |
IL (2) | IL144559A0 (fr) |
PT (1) | PT1157041E (fr) |
WO (1) | WO2000052054A2 (fr) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030180290A1 (en) * | 1995-06-07 | 2003-09-25 | Idec Pharmaceuticals Corporation | Anti-CD80 antibody having ADCC activity for ADCC mediated killing of B cell lymphoma cells alone or in combination with other therapies |
IL144559A0 (en) | 1999-03-01 | 2002-05-23 | Genentech Inc | Antibodies for cancer therapy and diagnosis |
SE0000597D0 (sv) * | 2000-02-24 | 2000-02-24 | Active Biotech Ab | Novel antibody |
US7097840B2 (en) * | 2000-03-16 | 2006-08-29 | Genentech, Inc. | Methods of treatment using anti-ErbB antibody-maytansinoid conjugates |
US20020115065A1 (en) * | 2000-08-28 | 2002-08-22 | Ton Logtenberg | Differentially expressed epitopes and uses thereof |
WO2002022685A2 (fr) * | 2000-09-11 | 2002-03-21 | Kufe Donald W | Domaine extracellulaire du muc1 et compositions et procedes pour le traitement du cancer derives de celui-ci |
US7611711B2 (en) | 2001-01-17 | 2009-11-03 | Vegenics Limited | VEGFR-3 inhibitor materials and methods |
WO2002060485A2 (fr) * | 2001-01-31 | 2002-08-08 | Idec Pharmaceuticals Corporation | Anticorps immunoregulateurs et ses utilisations |
US20030103971A1 (en) * | 2001-11-09 | 2003-06-05 | Kandasamy Hariharan | Immunoregulatory antibodies and uses thereof |
KR100906102B1 (ko) | 2001-03-27 | 2009-07-07 | 사무엘 보고치 | 레플리킨 펩타이드 및 그의 이용 |
US7774144B2 (en) | 2001-10-26 | 2010-08-10 | Samuel Bogoch | System and method for identifying complex patterns of amino acids |
US7189800B2 (en) | 2001-03-27 | 2007-03-13 | Samuel Bogoch | Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
EP1270732A1 (fr) * | 2001-06-21 | 2003-01-02 | Schuler, Gerold | Transfection de cellules eucaryotes avec des polynucléotides linéaires par électroporation |
KR20040044850A (ko) * | 2001-09-05 | 2004-05-31 | 제넨테크, 인크. | 이상 세포 증식을 포함하는 질환에 연관된 폴리펩티드항원의 인식을 위한 방법 및 상기 질환 치료에 유용한조성물 |
US8455627B2 (en) * | 2001-10-05 | 2013-06-04 | Affimed Therapeutics, Ag | Human antibody specific for activated state of platelet integrin receptor GPIIb/IIIa |
ES2288900T3 (es) * | 2001-10-05 | 2008-02-01 | Affimed Therapeutics Ag | Anticuerpo de origen humano para inhibir la agregacion de trombocitos. |
US8435529B2 (en) | 2002-06-14 | 2013-05-07 | Immunomedics, Inc. | Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy |
AU2003209447B8 (en) * | 2002-03-01 | 2008-10-23 | Immunomedics, Inc. | RS7 antibodies |
US9745380B2 (en) * | 2002-03-01 | 2017-08-29 | Immunomedics, Inc. | RS7 antibodies |
US9770517B2 (en) * | 2002-03-01 | 2017-09-26 | Immunomedics, Inc. | Anti-Trop-2 antibody-drug conjugates and uses thereof |
JP5138867B2 (ja) * | 2002-08-01 | 2013-02-06 | イミューノメディクス、インコーポレイテッド | α−フェトタンパク質Immu31抗体および融合タンパク質ならびにその使用方法 |
GB2392723B (en) | 2002-09-04 | 2005-01-12 | Bioinvent Int Ab | Screening methods |
GB0227644D0 (en) * | 2002-11-27 | 2003-01-08 | Cancer Rec Tech Ltd | Specific binding members and uses thereof |
US8088387B2 (en) | 2003-10-10 | 2012-01-03 | Immunogen Inc. | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
US8494781B2 (en) | 2003-06-06 | 2013-07-23 | Samuel Bogoch | Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds |
AU2004293502B2 (en) * | 2003-11-28 | 2010-12-02 | National Research Council Of Canada | Anticarcinoma antibodies and uses thereof |
US20070178072A1 (en) * | 2004-03-31 | 2007-08-02 | Kirin Beer Kabushiki Kaisha | Method for inducing differentiation of regulatory t cells usinggip-anchored protein agonist and pharmaceutical composition therefor ( as amended |
US9254315B2 (en) | 2004-04-28 | 2016-02-09 | Samuel Bogoch | Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds |
EP1623996A1 (fr) * | 2004-08-06 | 2006-02-08 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Procédé amélioré de selection d'une protéine desirée d'une bibliothéque. |
WO2006049498A1 (fr) * | 2004-11-05 | 2006-05-11 | Modiquest B.V. | Moyens et procedes d'isolement et/ou d'identification d'une molecule cible |
US20050181479A1 (en) * | 2005-03-04 | 2005-08-18 | Medimmune, Inc. | Periplasmic expression of antibodies using a single signal sequence |
EP1885396A2 (fr) * | 2005-05-04 | 2008-02-13 | Quark Pharmaceuticals, Inc. | Anticorps recombinants diriges contre cd55 et cd59 et leur utilisation |
US8211648B2 (en) * | 2005-07-22 | 2012-07-03 | Kalobios Pharmaceuticals, Inc. | Secretion of antibodies without signal peptides from bacteria |
US20070104717A1 (en) * | 2005-09-12 | 2007-05-10 | Regents Of The University Of Michigan | Compositions and methods for detecting and treating cancer |
TW200812615A (en) | 2006-03-22 | 2008-03-16 | Hoffmann La Roche | Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2 |
AU2008266702A1 (en) | 2007-05-30 | 2008-12-24 | Elenore S. Bogoch | Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture |
NO2195023T3 (fr) | 2007-08-29 | 2018-08-04 | ||
AU2013203265B2 (en) * | 2007-08-29 | 2016-06-23 | Sanofi | Humanized anti-CXCR5 antibodies, derivatives thereof and their uses |
WO2010105235A2 (fr) | 2009-03-12 | 2010-09-16 | Cancer Prevention And Cure, Ltd. | Procédés d'identification, d'évaluation, de prévention et de thérapie de maladies des poumons et leurs kits comprenant une identification, une évaluation, une prévention et une thérapie de maladies basées sur le sexe |
US8541183B2 (en) | 2007-09-11 | 2013-09-24 | Cancer Prevention And Cure, Ltd. | Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof |
EP2088432A1 (fr) * | 2008-02-11 | 2009-08-12 | MorphoSys AG | Procédés pour l'identification d'un anticorps ou d'une cible |
US9233148B2 (en) | 2009-01-09 | 2016-01-12 | Samuel Bogoch | Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza |
MX2011012696A (es) | 2009-05-29 | 2012-03-29 | Morphosys Ag | Una coleccion y metodos para su uso. |
SG189950A1 (en) | 2010-11-19 | 2013-06-28 | Morphosys Ag | A collection and methods for its use |
WO2012149550A1 (fr) | 2011-04-29 | 2012-11-01 | Cancer Prevention And Cure, Ltd. | Procédés d'identification et de diagnostic de maladies pulmonaires à l'aide de systèmes de classification et leurs kits |
AU2012283914A1 (en) | 2011-07-20 | 2014-01-30 | Bogoch, Elanore S. | Peptides shared among lethal cancers and therapeutic compositions comprising said peptides |
GB201116364D0 (en) | 2011-09-22 | 2011-11-02 | Bioinvent Int Ab | Screening methods and uses thereof |
US9592289B2 (en) | 2012-03-26 | 2017-03-14 | Sanofi | Stable IgG4 based binding agent formulations |
US9382329B2 (en) | 2012-08-14 | 2016-07-05 | Ibc Pharmaceuticals, Inc. | Disease therapy by inducing immune response to Trop-2 expressing cells |
JP6746845B2 (ja) | 2015-04-22 | 2020-08-26 | イミューノメディクス、インコーポレイテッドImmunomedics, Inc. | 循環trop−2陽性癌細胞の単離、検出、診断及び/または特徴付け |
KR101875912B1 (ko) * | 2016-10-13 | 2018-07-06 | 한국원자력연구원 | 암 표적 치료를 위한 방사성 동위원소가 표지된 cd55 표적 항체 및 이의 용도 |
JP7250693B2 (ja) | 2017-04-04 | 2023-04-03 | ラング キャンサー プロテオミクス, エルエルシー | 初期ステージの肺がん診断のための血漿ベースのタンパク質プロファイリング |
EP3927367A4 (fr) * | 2019-02-20 | 2022-11-30 | Agonox, Inc. | Anticorps anti-cd55, compositions associées et procédés associés |
CN116646088B (zh) * | 2023-07-27 | 2023-12-01 | 广东省人民医院 | 一种预测方法、装置、设备及介质 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
EP0223842A4 (fr) * | 1985-05-24 | 1987-08-24 | Univ New York | Anticorps monoclonal du facteur d'acceleration de la decomposition (fad), son procede de production et d'utilisation. |
US5374548A (en) | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
AU634181B2 (en) | 1988-10-17 | 1993-02-18 | Cancer Research Campaign Technology Limited | Anti-idiotypic antibody induction of antitumor response |
US5565332A (en) | 1991-09-23 | 1996-10-15 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
WO1994026787A1 (fr) | 1993-05-07 | 1994-11-24 | The Board Of Trustees Of The Leland Stanford Junior University | Procede pour generer des bibliotheques d'anticorps de phages specifiques de types cellulaires |
EP0733070A1 (fr) | 1993-12-08 | 1996-09-25 | Genzyme Corporation | Procede de generation d'anticorps specifiques |
JP3562834B2 (ja) | 1994-06-01 | 2004-09-08 | 孝夫 辻 | 便中daf分子の検査方法 |
US6140470A (en) | 1995-06-30 | 2000-10-31 | Yale University | Human monoclonal anti-tumor antibodies |
PT1516628E (pt) | 1995-07-27 | 2013-09-24 | Genentech Inc | Formulação de proteína liofilizada isotónica estável |
AU4474497A (en) | 1996-10-08 | 1998-05-05 | U-Bisys B.V. | Methods and means for selecting peptides and proteins having specific affinity for a target |
US5985543A (en) | 1996-10-11 | 1999-11-16 | The Trustees Of The University Of Pennsylvania | Compositions and methods for detection of antibody binding to cells |
AU6451998A (en) | 1997-03-06 | 1998-09-22 | Bard Diagnostic Sciences, Inc. | Screening and treatment using complement regulator or receptor proteins |
DE69830901T2 (de) * | 1997-05-02 | 2006-05-24 | Genentech Inc., San Francisco | ein verfahren zur herstellung multispezifischer antikörper die heteromultimere und gemeinsame komponenten besitzen |
GB9804065D0 (en) * | 1998-02-26 | 1998-04-22 | Cancer Res Campaign Tech | Tumour associated antigen 791Tgp72 |
US6794128B2 (en) | 1998-04-24 | 2004-09-21 | The Regents Of The University Of California | Methods of selecting internalizing antibodies |
IL144559A0 (en) | 1999-03-01 | 2002-05-23 | Genentech Inc | Antibodies for cancer therapy and diagnosis |
US20030129677A1 (en) * | 2000-05-12 | 2003-07-10 | Martens Mark G. | Diagnostic method for screening complement regulatory protein levels |
US20070104717A1 (en) * | 2005-09-12 | 2007-05-10 | Regents Of The University Of Michigan | Compositions and methods for detecting and treating cancer |
-
2000
- 2000-02-29 IL IL14455900A patent/IL144559A0/xx active IP Right Grant
- 2000-02-29 CA CA002361877A patent/CA2361877A1/fr not_active Abandoned
- 2000-02-29 ES ES00912115T patent/ES2243240T3/es not_active Expired - Lifetime
- 2000-02-29 EP EP00912115A patent/EP1157041B1/fr not_active Revoked
- 2000-02-29 AT AT00912115T patent/ATE296839T1/de not_active IP Right Cessation
- 2000-02-29 DE DE60020529T patent/DE60020529T2/de not_active Revoked
- 2000-02-29 WO PCT/US2000/005352 patent/WO2000052054A2/fr active IP Right Grant
- 2000-02-29 AU AU33898/00A patent/AU770952B2/en not_active Expired
- 2000-02-29 PT PT00912115T patent/PT1157041E/pt unknown
- 2000-02-29 JP JP2000602278A patent/JP2002543044A/ja not_active Withdrawn
-
2001
- 2001-07-25 IL IL144559A patent/IL144559A/en not_active IP Right Cessation
-
2003
- 2003-05-28 US US10/447,331 patent/US7288249B2/en not_active Expired - Lifetime
-
2007
- 2007-06-19 US US11/765,336 patent/US20080166698A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU770952B2 (en) | 2004-03-11 |
DE60020529D1 (de) | 2005-07-07 |
ATE296839T1 (de) | 2005-06-15 |
IL144559A (en) | 2006-12-10 |
EP1157041B1 (fr) | 2005-06-01 |
ES2243240T3 (es) | 2005-12-01 |
WO2000052054A3 (fr) | 2001-08-23 |
DE60020529T2 (de) | 2006-04-27 |
US20030219434A1 (en) | 2003-11-27 |
JP2002543044A (ja) | 2002-12-17 |
EP1157041A2 (fr) | 2001-11-28 |
WO2000052054A2 (fr) | 2000-09-08 |
AU3389800A (en) | 2000-09-21 |
US20080166698A1 (en) | 2008-07-10 |
US7288249B2 (en) | 2007-10-30 |
PT1157041E (pt) | 2005-10-31 |
CA2361877A1 (fr) | 2000-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL144559A0 (en) | Antibodies for cancer therapy and diagnosis | |
MY136095A (en) | Use of human anti-ctla-4 antibodies for treatment of cancer | |
MXPA02011656A (es) | Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos. | |
MXPA02000192A (es) | Composiciones y metodos para la terapia y diagnostico de cancer de pulmon. | |
IL127558A0 (en) | Hepatocyte growth factor receptor agonists and uses thereof | |
FR2523445B1 (fr) | ||
TR200103560T2 (tr) | Göğüs kanserinin teşhis ve tedavisi için bileşimler ve bunların kullanımı | |
ZA99693B (en) | Compounds for therapy and diagnosis of lung cancer and methods for their use. | |
IL147017A0 (en) | TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES | |
MXPA03000527A (es) | Composiciones y metodos para la terapia y diagnostico de cancer ovarico. | |
TW200728465A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
PL335334A1 (en) | Combined treatment involing suppressor gene tumour therapy and chemotherapy for use in antineoplastic therapy | |
AU2001247968A1 (en) | Use of asiatic acid or asiaticoside for treatment of cancer | |
CA2132001A1 (fr) | Methodes de traitement du cancer au moyen de la proteine c-reactive modifiee | |
MXPA03011306A (es) | Metodos para la preparacion y uso de 1a,24 (s) - hidroxivitamina d2. | |
WO2000052165A3 (fr) | Compositions et methodes de therapie et de diagnostic du cancer du sein | |
HK1068251A1 (en) | Aminoderivatives of biotin and their conjugates with macrocyclic chelating agents | |
BR0111024A (pt) | Composições e métodos para a terapia e diagnóstico de câncer de mama | |
WO1992018536A3 (fr) | Procede de detection et de localisation de tissus comprenant des recepteurs de neurokinine 1 | |
WO2004047757A3 (fr) | Diagnostic et traitement des cancers hematopoietiques | |
WO2004010951A8 (fr) | Methode de traitement des tumeurs | |
AU2002228940A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
WO2000004153A3 (fr) | Inhibition de la transformation cellulaire par la proteine pea3 humaine | |
AU4042795A (en) | Treatment of non-small cell lung carcinoma | |
ZA981558B (en) | Inclusion complexes in aqueous solution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
FF | Patent granted | ||
KB | Patent renewed |